ACE gene titration in mice uncovers a new mechanism for ACE on the control of body weight

Physiological Genomics

Volumn 20, Issue , 2005, Pages 173-182

  Heimann, A S ^a   Favarato, M H ^a   Gozzo, F C ^b   Rioli, V ^a   Carreno F R ^a   Eberlin, M N ^b   Ferro, E S ^a   Krege, J H ^c   Krieger, J E ^a,d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d Laboratory of Molecular Genetics   (Brazil)

Author keywords

Angiotensin converting enzyme; EP24.16; Insulin resistance; Oligopeptides; Peptides

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; FAT; NEUROLYSIN; OLIGOPEPTIDE; PEPTIDE; PROTEIN KINASE C; THIMET OLIGOPEPTIDASE;

ADIPOSE TISSUE; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; EPIDIDYMIS FAT; GENE DUPLICATION; GENE IDENTIFICATION; GENE LOCUS; LIPID DIET; LIQUID CHROMATOGRAPHY; MALE; METABOLIC ACTIVATION; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; CHROMATOGRAPHY, LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; METALLOENDOPEPTIDASES; MICE; MICE, TRANSGENIC; MODELS, STATISTICAL; OLIGOPEPTIDES; PEPTIDE HYDROLASES; PEPTIDES; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE; PHOSPHORYLATION; PROTEIN KINASE C; RISK FACTORS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 15244340432     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00145.2004     Document Type: Article

References (62)

1. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, and Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402, 1997.
2. Araujo MC, Melo RL, Cesari MH, Juliano MA, Juliano L, and Carmona AK. Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme. Biochemistry 39: 8519-8525, 2000.
3. Bader M, Peters J, Baltatu O, Muller DN, Uft FC, and Ganten D. Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 79: 76-102, 2001.
4. Barsh GS, Farooqi IS, and O'Rahilly T. Genetics of body-weight regulation. Nature 404: 644-651, 2000.
5. Barsh GS and Schwartz MW. Genetic approaches to studying energy balance: perception and integration. Nat Rev 3: 589-600, 2002.
6. Barton M, Carmona R, Ortmann J, Krieger JE, and Traupe T. Obesity-associated activation of angiotensin and endothelin in the cardiovascular system. Int J Biochem Cell Biol 35: 826-837, 2003.
7. Bonny C, Oberson A, Negri S, Sauser C, and Schorderet DF. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 50: 77-82, 2001.
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
9. Brasier AR, Recinos A III, and Eledrisi MS. Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 22: 1257-1266, 2002.
10. Brown CK, Madauss K, Lian W, Beck MR, Tolbert WD, and Rodgers DW. Structure of neurolysin reveals a deep channel that limits substrate access. Proc Natl Acad Sci USA 98: 3127-3132, 2001.
11. Burcelin R, Crivelli V, Dacosta A, Roy-Tirelli A, and Thorens B. Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. Am J Physiol Endocrinol Metab 282: E834-E842, 2002; doi:10.1152/ajpendo.00332.2001.
12. Burns-Hamuro LL, Ma Y, Kammerer S, Reineke U, Self C, Cook C, Olson GL, Cantor CR, Braun A, and Taylor SS. Designing isoform-specific peptide disruptors of protein kinase A localization. Proc Natl Acad Sci USA 100: 4072-4077, 2003.
13. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, and Luc G. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 90: 669-676, 1994.
14. Campbell DJ, Alexiou T, Xiao HD, Fuchs S, McKinley MJ, Corvol P, and Bernstein KE. Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice. Hypertension 24: 854-859, 2004.
15. Caron KMI, James LR, Kim HS, Morham SG, Lopez MLSS, Gomez RA, Reudelhuber TL, and Smithies O. A genetically clamped renin transgene for the induction of hypertension. Proc Natl Acad Sci USA 99: 8248-8252, 2002.
16. Che FY, Yan L, Li H, Mzhavia N, Devi LA, and Fricker LD. Identification of peptides from brain and pituitary of Cpefat/Cpefat mice. Proc Natl Acad Sci USA 98: 9971-9976, 2001.
17. Conarello SL, Li Z, Ronan J, Roy RS, Zhu L, Jiang G, Liu F, Woods J, Zycband E, Moller DE, Thornberry NA, and Zhang BB. Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance. Proc Natl Acad Sci USA 100: 6825-6830, 2003.
18. Crandall DL, Armellino DC, Busler DE, McHendry-Rinde B, and Kral JG. Angiotensin II receptors in human preadipocytes: Role in cell cycle regulation. Endocrinology 140: 154-158, 1999.
19. Dauch P, Vincent JP, and Checler F. Specific inhibition of endopeptidase 24.16 by dipeptides. Eur J Biochem 202: 269-276, 1991.
20. Dzau VJ, Bernstein K, Celermajer D, Cohen J, Deanfield J, Diez J, Drexler H, Ferrari R, Van Gilst W, Hansson L, Hornig B, Husain A, Lazar H, Lonn E, Luscher T, Mancini J, Mimran A, Pepine C, Rabelink T, Remme W, Ruilope L, Ruzicka M, Schunkert H, Swedberg K, Unger T, Vaughan D, and Weber M. Pathophysiologic and therapeutic importance of tissue ACE: a consensus report. Cardiovasc Drugs Ther 16: 149-160, 2002.
21. Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G, Teboul M, Massiera F, and Sharma AM. The adipose-tissue reninangiotensin- aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 35: 807-825, 2003.
22. Falquet L, Pagni M, Bucher P, Hulo N, Sigrist CJA, Hofmann K, and Bairoch A. The PROSITE database, its status in 2002. Nucleic Acids Res 30: 235-238, 2002.
23. Fricker LD and Leiter EH. Peptides, enzymes and obesity: new insights from a "dead" enzyme. Trends Biochem Sci 24: 390-393, 1999.
24. Friedman MJ. Obesity in the new millennium. Nature 404: 632-634, 2000.
25. Fruitier-Arnaudin I, Cohen M, Bordenave S, Sannier F, and Piot JM. Comparative effects of angiotensin IV and two hemorphins on angiotensin- converting enzyme activity. Peptides 23: 1465-1470, 2002.
26. Gallouzi IE and Steitz JA. Delineation of mRNA export pathways by the use of cell-permeable peptides. Science 294: 1895-1901, 2001.
27. Hillebrand JJG, Wied D, and Adan RAH. Neuropeptides, food intake and body weight regulation: a hypothalamic focus. Peptides 23: 2283-2306, 2002.
28. Ishida A, Kameshita I, Okuno S, Kitani T, and Fujisawa H. A novel highly specific and potent inhibitor of calmodulin-dependent protein kinase II. Biochem Biophys Res Commun 212: 806-812, 1995.
29. Ivanov VT, Karelin AA, Philippova MM, Nazimov IV, and Pletnev VZ. Hemoglobin as a source of endogenous bioactive peptides: the concept of tissue-specific peptide pool. Biopolymers 43: 171-188, 1997.
30. Flier JS. Obesity wars: molecular progress confronts an expanding epidemic. Cell 116: 337-350, 2004.
31. Junghans P, Kaehne T, Beyer M, Metges CC, and Schwerin M. Dietary protein-related changes in hepatic transcription correspond to modifications in hepatic protein expression in growing pigs. J Nutr 134: 43-47, 2004.
32. Kim SI, Grum-Tokars V, Swanson TA, Cummins PM, and Glucksman MJ. Novel roles of neuropeptide processing enzymes: EC3.4.24.15 in the neurone. J Neurosci Res 74: 456-467, 2003.
33. Krege JH, John SW, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O'Brien DA, and Smithies O. Male female differences in fertility and blood pressure in ACE-deficient mice. Nature 375: 146-148, 1995.
34. Krege JH, Moyer JS, Langenbach LL, Peng L, Zhang SH, Maeda N, Reddick RL, and Smithies O. Angiotensin-converting enzyme gene and atherosclerosis. Arterioscler Thromb Vasc Biol 17: 1245-1250, 1997.
35. Lee MA, Bohm M, Paul M, and Ganten D. Tissue renin-angiotensin systems. Their role in cardiovascular disease. Circulation 87: IV7-IV13, 1993.
36. Lee VHL. Membrane transporters. Eur J Pharm Sci 11: S41-S50, 2000.
37. Leung PS and Carlsson PO. Tissue renin-angiotensin system: its expression, localization, regulation and potential role in the pancreas. J Mol Endocrinol 26: 155-164, 2001.
38. Lijnen P and Petrov V. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. J Mol Cell Cardiol 31: 949-970, 1999.
39. Lusis AJ and LeBoeuf RC. Genetic control of plasma lipid transport: mouse model. Methods Enzymol 128: 877-894, 1986.
40. Natesh R, Schwager SL, Sturrock ED, and Acharya KR. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 421: 551-554, 2003.
41. Oliveri C, Ocaranza MP, Campos X, Lavandero S, and Jalil JE. Angiotensin I-converting enzyme modulates neutral endopeptidase activity in the rat. Hypertension 38: 650-654, 2001.
42. Paigen B, Holmes PA, Mitchell D, and Albee D. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H. Atherosclerosis 64: 215-221, 1987.
43. Paigen B, Ishida BY, Verstuyft J, Winters RB, and Albee D. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis 10: 316-323, 1990.
44. Paigen B, Mitchell D, Holmes PA, and Albee D. Genetic analysis of strains C57BL/6J and BALB/cJ for Ath-1, a gene determining atherosclerosis susceptibility in mice. Biochem Genet 25: 881-892, 1987.
45. Panahloo A, Andres C, Mohamed-Ali V, Gould MM, Talmud P, Humphries SE, and Yudkin JS. The insertion allele of the ACE gene I/D polymorphism: A candidate gene for insulin resistance? Circulation 92: 3390-3393, 1995.
46. Pawson T and Scott JD. Signalling through scaffold, anchoring, and adaptor proteins. Science 278: 2075-2080, 1997.
47. Portaro FC, Gomes MD, Cabrera A, Fernandes BL, Silva CL, Ferro ES, Juliano L, and de Camargo ACM. Thimet oligopeptidase and the stability of MHC class I epitopes in macrophage cytosol. Biochem Biophys Res Commun 255: 596-601, 1999.
48. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
49. Rioli V, Gozzo FC, Heimann AS, Linardi A, Krieger JE, Shida CS, Almeida PC, Hyslop S, Eberlin MN, and Ferro ES. Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme. J Biol Chem 278: 8547-8555, 2003.
50. Ryan AS, Nicklas BJ, Berman DM, and Ferrell RE. The insertion/deletion polymorphism of the ACE gene is related to insulin sensitivity in overweight women. Diabetes Care 24: 1646-1652, 2001.
51. Saltiel AR and Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799-806, 2001.
52. Silva CL, Portaro FC, Bonato VL, de Camargo AC, and Ferro ES. Thimet oligopeptidase (EC 3.4.24.15), a novel protein on the route of MHC class I antigen presentation. Biochem Biophys Res Commun 255: 591-595, 1999.
53. Smith BK, Andrews PK, and West DB. Macronutrient diet selection in thirteen mouse strains. Am J Physiol Regul Integr Comp Physiol 278: R797-R805, 2000.
54. Strazzullo P, Iacone R, Iacoviello L, Russo O, Barba G, Russo P, D'Orazio A, Barbato A, Cappuccio FP, Farinaro E, and Siani A. Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study. Ann Intern Med 138: 17-23, 2003.
55. Takahashi N, Hagaman JR, Kim HS, and Smithies O. Computer simulations of blood pressure regulation by the renin-angiotensin system. Endocrinology 144: 2184-2190, 2003.
56. Tanasijevic MJ, Myers MG Jr, Thoma RS, Crimmins DL, White MF and Sacks DB. Phosphorylation of the insulin receptor substrate IRS-1 by casein kinase II. J Biol Chem 268: 18157-18166, 1993.
57. Thomas GN, Tomlinson B, Chan JCN, Sanderson JE, Cockram CS, and Critchley JAJH. Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: A significant association of the ACE insertion/deletion polymorphism with type 2 diabetes. Diabetes Care 24: 356-361, 2001.
58. Tian B, Meng QC, Chen YF, Krege JH, Smithies O, and Oparil S. Blood pressures and cardiovascular homeostasis in mice having reduced or absent angiotensin-converting enzyme gene function. Hypertension 30: 128-133, 1997.
59. Tullai JW, Cummins PM, Pabon A, Roberts JL, Lopingco MC, Shrimpton CN, Smith AI, Martignetti JA, Ferro ES, and Glucksman MJ. The neuropeptide processing enzyme EC 3.4.24.15 is modulated by protein kinase A phosphorylation. J Biol Chem 275: 36514-36522, 2000.
60. Velloso LA, Folli F, Sun XJ, White MF, Saad MJ, and Kahn CR. Cross-talk between the insulin and angiotensin signalling systems. Proc Natl Acad Sci USA 93: 12490-12495, 1996.
61. Yamanaka C, Lebrethon MC, Vandersmissen E, Gerard A, Purnelle G, LeMaitre M, Wilk S, and Bourguignon JP. Early prepubertal ontogeny of pulsatile gonadotropin-releasing hormone (GnRH) secretion. I. Inhibitory autofeedback control through prolyl endopeptidase degradation of GnRH. Endocrinology 140: 4609-4615, 1999.
62. Zorad S, Fickova M, Zelezna B, Macho L, and Kral JG. The role of angiotensin II and its receptors in regulation of adipose ussue metabolism and cellularity. Gen Physiol Biophys 14: 383-391, 1995.